2011 | | Effect of sitagliptin plus metformin on β-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats. | 강엽, 김대중, 김혜진, 이관우, 한승진 |
2022 | | Effects of co-administration of metformin and evogliptin on cerebral infarct volume in the diabetic rat | 이성준, 이진수, 조은혜, 홍지만 |
2023 | | Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study | 이관우 |
2007 | | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 김대중, 이관우 |
2023 | | Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension | 김혜진 |
2017 | | Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study) | 이관우 |
2024 | | Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial | 김범택 |
2019 | | Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial | 이관우 |
2023 | | Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study | 김대중, 하경화 |
2023 | | Empagliflozin is associated with lower risk of cardiovascular events and all-cause mortality in routine care in East Asia: Results from the EMPRISE study | 김대중, 하경화 |
2018 | | Failure of monotherapy in clinical practice in patients with type 2 diabetes: The Korean National Diabetes Program | 김대중, 김혜진, 이관우, 전자영, 한승진 |
2011 | | Fat redistribution preferentially reflects the anti-inflammatory benefits of pioglitazone treatment. | 김혜진 |
2004 | | Glucose uptake-stimulatory activity of Amomi Semen in 3T3-L1 adipocytes. | 강엽 |
2022 | | Healthcare resource utilization in patients treated with empagliflozin in East Asia | 김대중, 하경화 |
2000 | | HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. | 김현만, 정윤석 |
2019 | | Hospital-Based Korean Diabetes Prevention Study: A Prospective, Multi-Center, Randomized, Open-Label Controlled Study | 이관우 |
2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study | 김대중, 김혜진, 문소영, 이관우, 전자영, 한승진 |
2020 | | Hypoglycemia and Dementia Risk in Older Patients with Type 2 Diabetes Mellitus: A Propensity-Score Matched Analysis of a Population-Based Cohort Study (Diabetes Metab J 2020;44:125-33) | 한승진 |
2016 | | Hypoglycemia is associated with dementia in elderly patients with type 2 diabetes mellitus: An analysis based on the Korea National Diabetes Program Cohort | 이관우, 전기홍 |
2017 | | Impact of clinical evidence communications and drug regulation changes concerning rosiglitazone on prescribing patterns of antidiabetic therapies | 김대중, 이광재 |
2020 | | Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism | 이해상, 황진순 |
2016 | | Increased postprandial apolipoprotein B-48 level after a test meal in diabetic patients: A multicenter, cross-sectional study | 김대중 |
2015 | | Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension. | 이관우 |
2018 | | Long-term effects on glycaemic control and beta-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial | 이관우 |
2018 | | Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort | 김대중, 김혜진, 이관우, 전기홍, 전자영, 한승진 |
1999 | | Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I. | 곽병주, 노재성, 주일로 |
2018 | | Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy | 송지훈, 이기황, 정유리 |
2005 | | Predictive clinical parameters for therapeutic efficacy of rosiglitazone in Korean type 2 diabetes mellitus. | 김대중 |
2006 | | Prevalence of erectile dysfunction in Korean men with Type 2 diabetes mellitus. | 조남한 |
2016 | | Psychometric Evaluation of a Korean Version of the Adherence to Refills and Medications Scale (ARMS) in Adults With Type 2 Diabetes | 김대중, 김춘자 |
2019 | | PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin | 변혜은, 이다근 |
2018 | | Relationships of health literacy to self-care behaviors in people with diabetes aged 60 and above: Empowerment as a mediator | 이은현 |
2016 | | Risk factors of severe hypoglycemia requiring medical assistance and neurological sequelae in patients with diabetes: A case-control study | 김대중, 김혜진, 이관우, 전자영, 한승진 |
2021 | | Safety and effectiveness of linagliptin in Korean patients with type 2 diabetes: A postmarketing surveillance study | 정윤석 |
2019 | | Second-line glucose-lowering drugs added to metformin and the risk of hospitalization for heart failure: A nationwide cohort study | 김대중, 하경화 |
2006 | | The 11482G >A polymorphism in the perilipin gene is associated with weight gain with rosiglitazone treatment in type 2 diabetes. | 김혜진 |
2007 | | The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats. | 김대중 |
2007 | | The increase in abdominal subcutaneous fat depot is an independent factor to determine the glycemic control after rosiglitazone treatment. | 김혜진 |
2006 | | The long-term effects of rosiglitazone on serum lipid concentrations and body weight. | 김혜진 |
2015 | | The role of social support on the relationship of depressive symptoms to medication adherence and self-care activities in adults with type 2 diabetes. | 김대중, 김춘자 |
1997 | | Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte culture. | 김승업 |
2016 | | Trends of antidiabetic drug use in adult type 2 diabetes in Korea in 2002-2013: Nationwide population-based cohort study | 김대중 |
2012 | | Two novel insulin receptor gene mutations in a patient with Rabson-Mendenhall syndrome: the first Korean case confirmed by biochemical, and molecular evidence | 손영배 |
2019 | | Utilization patterns of insulin for patients with type 2 diabetes from national health insurance claims data in South Korea | 김대중 |
1999 | | Zn2+ entry produces oxidative neuronal necrosis in cortical cell cultures. | 곽병주, 손성향, 조은혜 |